Dashboard
1
The company is Net-Debt Free
- Poor long term growth as Net Sales has grown by an annual rate of 12.33% and Operating profit at -8.67% over the last 5 years
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 7.46% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of 12.33% and Operating profit at -8.67% over the last 5 years
3
Flat results in Mar 26
4
With ROE of 2.06%, it has a very expensive valuation with a 2.36 Price to Book Value
Stock DNA
Pharmaceuticals & Biotechnology
CNY 4,327 Million (Small Cap)
119.00
NA
0.44%
0.93
2.06%
1.79
Revenue and Profits:
Net Sales:
1,286 Million
(Quarterly Results - Jun 2026)
Net Profit:
37 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-2.27%
0%
-2.27%
6 Months
21.71%
0%
21.71%
1 Year
29.97%
0%
29.97%
2 Years
75.82%
0%
75.82%
3 Years
12.56%
0%
12.56%
4 Years
-40.49%
0%
-40.49%
5 Years
-37.91%
0%
-37.91%
Shenzhen Sunnypol Optoelectronics Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
12.33%
EBIT Growth (5y)
-8.67%
EBIT to Interest (avg)
4.21
Debt to EBITDA (avg)
4.51
Net Debt to Equity (avg)
0.83
Sales to Capital Employed (avg)
0.62
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
40.16%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.15%
ROE (avg)
7.46%
Valuation key factors
Factor
Value
P/E Ratio
119
Industry P/E
Price to Book Value
2.45
EV to EBIT
68.31
EV to EBITDA
26.42
EV to Capital Employed
1.75
EV to Sales
2.13
PEG Ratio
NA
Dividend Yield
0.32%
ROCE (Latest)
2.56%
ROE (Latest)
2.06%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ
Jun'26
Mar'26
Change(%)
Net Sales
1,286.00
941.00
36.66%
Operating Profit (PBDIT) excl Other Income
119.20
131.10
-9.08%
Interest
14.60
13.70
6.57%
Exceptional Items
-2.30
-3.20
28.12%
Consolidate Net Profit
36.90
33.30
10.81%
Operating Profit Margin (Excl OI)
38.40%
65.10%
-2.67%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2026 is 36.66% vs -9.94% in Mar 2026
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2026 is 10.81% vs 1,485.71% in Mar 2026
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
3,683.40
2,581.50
42.68%
Operating Profit (PBDIT) excl Other Income
375.80
261.40
43.76%
Interest
63.70
37.20
71.24%
Exceptional Items
4.50
0.20
2,150.00%
Consolidate Net Profit
46.80
68.40
-31.58%
Operating Profit Margin (Excl OI)
35.30%
33.70%
0.16%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 42.68% vs 25.24% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -31.58% vs 59.44% in Dec 2024
About Shenzhen Sunnypol Optoelectronics Co., Ltd. 
Shenzhen Sunnypol Optoelectronics Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






